Novartis
About Novartis
Novartis AG is a Swiss multinational pharmaceutical corporation founded in 1996 (through merger of Ciba-Geigy and Sandoz), headquartered in Basel, Switzerland. Novartis explores quantum computing applications for drug discovery including molecular simulation, protein folding, drug-target interaction modeling, and pharmaceutical development. The company collaborates with quantum computing providers and quantum software companies developing quantum algorithms for computational drug discovery. Novartis investigates quantum machine learning for analyzing pharmaceutical data and quantum simulation for understanding complex biological molecules. The company serves global pharmaceutical industry requiring quantum-enhanced computational capabilities for drug discovery and development. Novartis advances quantum computing applications in pharmaceutical research demonstrating practical quantum applications for healthcare and drug discovery accelerating pharmaceutical development through quantum technology and quantum-enhanced computational chemistry.
2025 Developments: The company continues its quantum technology initiatives throughout 2025. Focus remains on advancing core technologies and expanding market presence. Ongoing development activities position the company for future growth in the quantum industry.
Company Information
- Founded: 1996
- Country: Switzerland
- Website: https://www.novartis.com
- Categories: quantum chemistry, drug discovery
Related Companies
Explore other quantum computing companies in similar categories or regions.